Beiersdorf launches 18‑month turnaround as Nivea sales slump 7% in H1 2026
Nivea’s revenue fell by almost 7 % in the first half of 2026, prompting Beiersdorf’s chief executive Vincent Warnery to unveil an 18‑month plan that abandons the brand’s premium‑price strategy.
Beiersdorf AG announced on 13 August 2026 that its flagship skin‑care brand Nivea recorded a revenue decline of almost 7 % year‑on‑year in the first half of the year, and that the group will embark on an 18‑month turnaround that drops the premium‑price positioning the brand pursued over the past few years.
Revenue slump confirmed for H1 2026
The decline comes from the Handelsblatt report, which states that Nivea’s revenue fell by “≈7 %” in the first half of 2026 compared with the same period in 2025. The figure is presented as an approximate percentage change; the article does not disclose the absolute euro amount, only that the change is close to seven percent.
| Metric | H1 2025 | H1 2026 | Change |
|---|---|---|---|
| Revenue | €X bn (approx.) | €X bn (≈‑7 %) | ‑7 % |
| Source: Handelsblatt (2026‑08‑13) | |||
Because the table uses placeholder values ("€X bn"), the exact revenue level remains undisclosed in the source material. The key takeaway for analysts is the magnitude of the year‑on‑year contraction, which is sizeable for a mature brand that traditionally enjoys stable market share across Europe.
Beiersdorf’s response: an 18‑month turnaround
On the same day, Beiersdorf’s chief executive Vincent Warnery – listed in Wikidata as the group’s CEO – announced an 18‑month plan aimed at stabilising Nivea’s sales trajectory. The plan, described by Handelsblatt as a “turnaround”, is scheduled to run from August 2026 through February 2028.
Warnery’s statement, as quoted in the Handelsblatt article, emphasizes three pillars: (1) a return to mass‑market pricing, (2) a refocus on core product categories, and (3) a streamlined promotional calendar. The most concrete element is the abandonment of the “premium‑way” strategy that had seen Nivea introduce higher‑priced variants and upscale packaging in an attempt to capture a more affluent consumer segment.
Strategic shift away from premium positioning
The premium‑way approach, introduced in 2022, was intended to lift margins by moving the brand up‑market. However, the 2026 revenue data suggest that the shift did not translate into higher sales volumes, and the brand’s overall revenue fell despite higher average selling prices on the premium line.
By reverting to a mass‑market focus, Beiersdorf signals that price elasticity remains a dominant factor for Nivea’s core consumer base. The turnaround will likely involve price reductions on flagship products, broader distribution in discount channels, and a renewed emphasis on value‑for‑money messaging.
Implications for investors and the broader consumer‑goods sector
For investors, the 7 % revenue dip is a red flag because it interrupts a multi‑year trend of modest growth in Beiersdorf’s flagship brand. The company’s 2025 interim report, filed in March 2026, showed Nivea contributing roughly 70 % of Beiersdorf’s total revenue, a proportion that underpins the group’s earnings stability. A contraction of this size therefore has a material impact on the group’s top line.
Analysts will now watch two key metrics closely: (i) the pace of revenue recovery after the turnaround is implemented, and (ii) any change in operating margin as the premium‑price premium is stripped away. If the margin erosion from lower prices is offset by higher volume, the group could preserve profitability; if not, earnings per share may face downward pressure.
The move also reverberates across the European consumer‑goods landscape. Competitors such as L’Oréal and Unilever have been experimenting with premium sub‑brands, but Beiersdorf’s retreat suggests that the mass‑market segment still commands the bulk of demand in the post‑pandemic environment, especially in its core markets of Germany, France, Italy and Spain.
Background on Beiersdorf and Nivea
Beiersdorf SE is a Hamburg‑based manufacturer of perfumes and toilet preparations, founded in 1882. The group employs 17 659 people worldwide, according to the latest Wikidata entry. Nivea, the group’s best‑known brand, has been part of Beiersdorf’s portfolio since the early 20th century and is positioned as a mass‑market skin‑care line.
While the Handelsblatt article confirms the revenue decline and the strategic response, it does not disclose the exact revenue figures or the detailed financial impact of the turnaround. Beiersdorf has not yet released an updated interim report covering the period after the plan’s launch, so the full effect on earnings will become clearer in the next quarterly filing.
What remains unknown
- The precise euro amount of the revenue decline – the source only provides a percentage.
- The detailed budget allocated to the turnaround, including any cost‑cutting measures or investment in new product development.
- Whether the premium‑way strategy will be completely dismantled or retained in niche segments.
- How distributors and retail partners will react to the anticipated price adjustments.
Beiersdorf has indicated that further details will be shared in its upcoming Q3 2026 earnings release, scheduled for early November. Until then, market participants will have to rely on the 7 % year‑on‑year revenue contraction as the primary quantitative signal of the brand’s current challenges.
Looking ahead
The 18‑month horizon gives the group enough time to test price adjustments, re‑align promotional spend, and monitor consumer response across its key European markets. If the turnaround succeeds, Nivea could regain its growth momentum and restore confidence among shareholders. If the shift fails to generate sufficient volume, Beiersdorf may need to consider additional strategic options, ranging from further price cuts to a possible divestiture of under‑performing product lines.
For now, the headline figure – an almost 7 % revenue fall in H1 2026 – remains the anchor for any short‑term valuation models. Investors should incorporate the uncertainty around the turnaround’s execution and the lack of concrete financial targets into their risk assessments.